Liver Transplantation

Article	Citations
Issue Information ‐ Author Checklist	73
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	61
Incidence and risk factors for chronic rejection in pediatric liver transplantation	52
CAQ Corner: Deceased donor selection and management	50
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	49
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	48
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	46
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	43
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	42
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	40
Issue Information	38
Three problems, two viruses, and one man with a vision and voice: Larry Kramer, medical activist	35
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	34
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	32
Impact of acuity circles policy on ABO blood type–related waitlist outcomes in liver transplantation	31
Postoperative complications after liver transplantation: Are we making progress?	30
Comparative analysis of early post-transplant infections after DCD with hypothermic oxygenated liver perfusion and DBD liver transplantation: A retrospective cohort study	30
Acute liver failure: Do we have a consensus regarding management?	29
Graft survival after liver transplantation using portable normothermic machine perfusion at a US center	29
Safety and feasibility of duct-to-duct biliary anastomosis in pediatric liver transplantation: A single-center retrospective study	29
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	28
Machine learning improves post-transplantation HCC recurrence prediction	28
Making the best use of testing for blood phosphatidylethanol	26
Semaglutide is effective in achieving weight loss in liver transplant recipients	25
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	25

Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	24
A pilot randomized controlled trial of a transportation assistance program in liver transplant (TAP-LT) candidates	24
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	24
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	24
PRO: All patients should receive a palliative care consult during LT evaluation	23
Robotic liver transplantation: University of Modena experience	23
Letter to the Editor: Is viscoelastic testing missing ADAMTS13 depletion during liver transplantation?	23
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	22
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	22
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	22
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	22
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	22
Issue Information ‐ Author Checklist	22
Correlation or causation? Addressing the gap between oral dysbiosis and liver transplant outcomes	21
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	21
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	20
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	20
Erratum	20
When worlds collide	20
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	20
Letter to the Editor: A pioneer living donor liver transplantation with transgender man donor—Breaking down the barriers to organ donation in Latin America	19
Clinical diagnosis of sarcopenia: Is it finally ready for prime time?	19
Operational tolerance is not always permanent	19
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A noninvasive approach	18
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	17
Reply: Choledochoduodenostomy in pediatric liver transplantation—Technical feasibility versus long-term safety	17
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion	17
Portal hypertensive ischemic enteropathy without mesenteric thrombosis: Reversible with TIPS despite extreme hyperlactatemia	17
PRO: Is the management of ACLF better in a liver-dedicated ICU?	17
Liver transplantation for pediatric liver malignancies	17
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	17
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	16
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	16
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	16
Reply: Interpreting outcomes in early liver transplantation	16
Policy Corner: HCC exception update	16
Benchmarking the real-world transplant benefit in unresectable colorectal liver metastases: A preliminary external validity assessment of the TransMet trial	16
Bariatric surgery post-liver transplantation: A Belgian nationwide study	16
Reply: Is viscoelastic testing missing ADAMTS13 depletion during liver transplantation?	16
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	15
Twelve is the new fifteen: The evolving MELD paradigm	15
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	15
Liver parenchymal quality stratifies outcomes after hepatic resection for hepatocellular carcinoma	15
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	14
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	14
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	14
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	14
Cannabis and liver transplant: We need to chill, man	13
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	13
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	13

Outcomes using steatotic liver grafts: Will machines score the final goal?	13
Priority for kidney after liver transplantation: A safety net for all?	13
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	13
A new tool to predict future liver allograft dysfunction?	13
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	13
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	13
Issue Information	13
Looking for literal improvement in liver transplant outcomes	13
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	13
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	12
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	12
Navigating the road to liver transplantation equity	12
Frailty 1 year after liver transplant is associated with long-term mortality: From the Functional Assessment in Liver Transplantation (FrAILT) Study	12
Reply: ChatGPT and unknown clinical questions about liver transplantation	12
Long-term considerations following living liver donation—Guidelines from the 2025 ILTS-iLDLT consensus conference on living liver donor safety	12
Decompensated cirrhosis but low MELD—Should we wait or refer for liver transplantation?	12
A case of a positive phosphatidylethanol test from blood transfusion and implications for access to clinical care	12
From gut to graft: Can microbiota shape pediatric liver transplant outcomes?	12
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	12
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	12
Erratum: The Liver Frailty Index enhances mortality risk prediction above and beyond MELD 3.0 alone	11
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	11
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	11
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	11
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	11
Bacterascites confers poor patient prognosis beyond MELD prediction	11
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	11
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	11
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	11
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	11
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	11
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	11
Reply: Methodological considerations for predicting HCC recurrence after liver transplantation	11
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	11
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	11
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	11
Management of portal vein thrombosis in candidates for liver transplant	10
HepB-CpG vaccination: An alternate strategy to lifelong antiviral therapy in patients transplanted for chronic hepatitis B	10
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients	10
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	10
Reply: Is the SRTR metric “Survival on the Waitlist” still useful in the age of machine perfusion and short liver transplant wait times?	10
Geographic and structural variability in liver transplant outreach programs: A national survey of academic centers	10
Letter to the Editor: Estimating the cost of liver transplantation	10
RAPID progress: Living donor liver transplantation for unresectable colorectal liver metastases	10
Food environment as a determinant of post-transplant diabetes and regional variation in the United States	10
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	10
Letter to the Editor: Few-shot learning—A methodological bridge from pilot experiments to large-scale studies in refractory ascites research	10
Policy Corner: Polycystic liver disease MELD exception update	10
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	10
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	9
Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease	9
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	9
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	9
Radiating an advantage: Comparative outcomes in transarterial locoregional therapies favor radioembolization bridging for transplant candidates with hepatocellular carcinoma	9
Reply: Refining early allograft failure risk prediction after LDLT—The importance of including L-GrAFT and EASE scores as comparative benchmarks	9
Baseline oral microbiome associated with post-living donor liver transplant early complications within 6 months	9
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	9
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	8
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	8
Untangling the web of waitlist dropout in HCC	8
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	8
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	8
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	8
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	8
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	8
Does hepatectomy technique matter?	8
Safety, tolerability, and efficacy of GLP-1 receptor agonists (GLP-1 RA) in the management of post–liver transplant weight gain: A multicenter, observational study	8
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	8
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	8
Incidence and outcomes of liver retransplantation using living donor allografts in the US	8
Informatics-driven solutions for optimal care delivery in liver transplantation	8
Reply: Does MELD 3.0’s sex correction transport to a hepatitis B/D-enriched turkish transplant population?	8
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	8
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	8
No transplant candidate left behind	8
Financial burden of cirrhosis is significantly reduced after liver transplantation	8
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	8
Geospatial analysis of liver donation after death by drug intoxication	7
Barriers to liver transplant referral in safety net settings: A national provider survey	7
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	7

Reduction of hepatectomy times in Dutch organ procurement teams	7
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	7
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	7
Creation of a new VA liver transplantation center increased access and retained care within the Veterans Health Administration	7
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	7
Maximizing outcomes by donor-recipient age matching in liver transplantation	7
When the MELD is low, the bar is high—Gender-related disparities in early liver transplantation	7
“Winning the peace” against obesity in recipients of liver transplant	7
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	7
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	7
Beyond the taxonomy: Reconsidering stigma’s place in liver disease care	7
Fellows’ Corner	7
Portopulmonary hypertension: May we agree to disagree?	7
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	7
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	7
Every last detail—Managing hepatic artery thrombosis and stenosis in a time of organ scarcity	7
Reply: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	7
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	7
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	7
Reply: Estimating the cost of liver transplantation	7
The impact of alcohol-associated liver disease on famous athletes who received liver transplants	7
Second thoughts about second opinions for liver transplantation	7
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Strategies and outcomes of multiple bile duct reconstructions in living donor liver transplantation	7
Letter to the Editor: Anonymous living donation in pediatric liver transplantation—A tool for equity	7
Erratum	7
Policy Corner: Cholangitis exception update	7
Quantitative methods for optimizing patient outcomes in liver transplantation	7
Harmonizing therapeutic hierarchy and transplant benefit in HCC management	7
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	7
Development of multicenter consensus care plans for immunosuppression after pediatric liver transplant: Reducing variability, creating comparative efficacy opportunities	7
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	6
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	6
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	6
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	6
Letter to the Editor: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	6
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	6
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	6
Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review	6
Long‐term follow‐up of living liver donors	6
Reply: Graft inflow modulation by splenic artery ligation in live donor liver transplant recipients in different time frames—A parallax!	6
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	6
Living donor liver transplantation in infants 6 kg or less: Impact of graft type and size on postoperative outcomes	6
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	6
Letter to the Editor: Reconsidering fibrinolytic assessment and hemostatic management in liver transplantation	6
Retraction: Clinical utility of an automated pupillometer for assessing and monitoring recipients of liver transplantation	6
Organ monitoring and identification of ischemic liver injury during ex situ porcine liver machine perfusion—A randomized controlled study	6
Potential strategies in porcine liver xenotransplantation: A bridge to allotransplantation and beyond	6
A simple intraoperative score incorporating thromboelastometric parameters predicts early reoperation for bleeding after liver transplantation	6
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	6
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	6
The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery	6
A scoping review of nonmedical barriers to living donor liver transplant	6
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	6
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	6
Liver transplantation in well-selected patients with unresectable colorectal liver metastases	6
Rethinking the use of immunotherapy post-liver transplantation: Standardized protocols with low risk of rejection	6
Multi-modal machine learning highlights recipient genetic and clinical factors as primary drivers of post-transplant MASLD: A two-center study	6
Retraction: Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: Prediction of occurrence of leukopenia	6
A Modified liver donor risk index for pediatric liver transplant recipients	6
Efficiency of machine perfusion in pediatric liver transplantation	6
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	6
Salvaging the fatty liver for transplant: is short duration NMP enough?	6
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	6
Steatotic liver disease after pediatric liver transplantation	5
Postliver transplant acute cardiomyopathy: Role of prospective cardiac evaluation in immediate posttransplant period	5
Minimally invasive living donor liver transplantation: the future is here	5
Preemptive liver transplantation is essential for patients with severe BSEP deficiency	5
Efficacy and safety of adhesion barrier in living-donor liver transplantation with right liver graft to prevent delayed gastric emptying	5
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant	5
Role of extracorporeal membrane oxygenation as a salvage therapy for liver transplantation recipients in a high‐volume transplant center	5
The prophylactic use of tranexamic acid in orthotopic liver transplantation: A randomized placebo-controlled study	5
Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant	5
Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma	5
Prediction of portal venous pressure in living donor liver transplantation: A retrospective study	5
Fellows’ Corner	5
Letter to the Editor: Viability assessment and transplantation of fatty liver grafts using end-ischemic normothermic machine perfusion	5
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	5
Waitlist and posttransplant outcomes of pregnancy-related acute liver failure in the United States	5
Liver transplantation with uncontrolled versus controlled DCD donors using normothermic regional perfusion and ex-situ machine perfusion	5
Retraction: Initial Clinical Results of Orthotopic Liver Transplantation for Hepatic Alveolar Echinococcosis	5
Lower Child Opportunity Index is associated with increased health care utilization following pediatric liver transplantation	5
Neuromuscular electrical stimulation, muscle mass, and physical function decline in the early phase after living donor liver transplantation	5
Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden	5
Liver transplantation indications and strategies in polycystic liver disease: A european survey	5
Jehovah’s Witnesses: Challenges in liver disease management and in liver transplantation	5
	5
A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study	5
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	5
Reply: Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States	5
“To sleep—perchance to dream”: Daytime surgery start times for liver transplantation with ex situ normothermic machine perfusion	5
Beyond the operating room: Long-term care for living liver donors	5
Improved liver transplant outcomes for patients with hilar cholangiocarcinoma following implementation of the MMAT-3 policy	5
Transplantation for unresectable colorectal liver metastasis: Pragmatic considerations in the post-TransMet trial era	5
Strategic leadership and financial governance in liver transplantation: Global insights from the International Liver Transplantation Society Congress 2025	5